Shanghai GenePharma

Shanghai GenePharma is a leading biotechnology company specializing in the development and manufacturing of RNA-based therapeutics and research reagents. Established in 2003, the company has built a comprehensive technology platform encompassing siRNA, shRNA, and mRNA, providing services that range from custom oligonucleotide synthesis to large-scale CDMO production. GenePharma's internal drug development pipeline focuses on high-unmet-need areas such as oncology, metabolic disorders, and infectious diseases, utilizing advanced delivery systems like lipid nanoparticles (LNP) and GalNAc conjugation. With state-of-the-art GMP-compliant facilities in Shanghai and Suzhou, the company supports global pharmaceutical and academic partners in accelerating RNA-based drug discovery. GenePharma is recognized as one of the largest suppliers of RNAi products in China and is a key player in the global nucleic acid drug landscape.